Stockscreener 앱 받기
117.14
0.13%
0.15
시장 영업 전:
117.70
0.56
+0.48%
Axsome Therapeutics Inc 주식(AXSM)의 최신 뉴스
Axsome stock rating reiterated at Outperform by RBC, citing FDA flexibility - Investing.com
Vanguard Group Inc. Sells 25,537 Shares of Axsome Therapeutics, Inc. $AXSM - MarketBeat
Wyckoff Accumulation Phase Possible in Axsome Therapeutics Inc.2025 Big Picture & Growth Focused Investment Plans - classian.co.kr
Fox Run Management L.L.C. Acquires 7,465 Shares of Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axsome Therapeutics, Inc. $AXSM Shares Purchased by Invesco Ltd. - MarketBeat
Deutsche Bank AG Cuts Holdings in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Nuveen LLC Invests $48.19 Million in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Quant Tools Rank Axsome Therapeutics Inc. as High Risk High RewardJuly 2025 Technicals & Weekly High Conviction Trade Ideas - thegnnews.com
Versor Investments LP Acquires Shares of 19,615 Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axsome Therapeutics, Inc. $AXSM Shares Acquired by Charles Schwab Investment Management Inc. - MarketBeat
Axsome Therapeutics Inc. Approaches Support With Recovery in SightJuly 2025 Sector Moves & Stock Market Timing Techniques - sundaytimes.kr
What's Going On With Tonix Pharma Stock Monday?Tonix Pharmaceuticals (NASDAQ:TNXP) - Benzinga
Virtu Financial LLC Takes $931,000 Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
Informed Momentum Co LLC Purchases Shares of 42,222 Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
Can Axsome Therapeutics Inc. continue delivering strong returnsWeekly Profit Analysis & Fast Exit Strategy with Risk Control - thegnnews.com
Connor Clark & Lunn Investment Management Ltd. Has $20.52 Million Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
XTX Topco Ltd Sells 9,794 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
Cantor Fitzgerald Has Positive View of AXSM FY2026 Earnings - MarketBeat
Equities Analysts Set Expectations for AXSM Q3 Earnings - MarketBeat
HC Wainwright Issues Negative Estimate for AXSM Earnings - MarketBeat
Cantor Fitzgerald Issues Negative Forecast for AXSM Earnings - MarketBeat
Leerink Partnrs Issues Positive Forecast for AXSM Earnings - MarketBeat
Equities Analysts Issue Forecasts for AXSM Q3 Earnings - MarketBeat
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q2 2025 Earnings Call Transcript - MSN
Royal Bank Of Canada Raises Axsome Therapeutics (NASDAQ:AXSM) Price Target to $189.00 - MarketBeat
TD Asset Management Inc Takes Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
Axsome Therapeutics' (AXSM) Buy Rating Reiterated at Needham & Company LLC - MarketBeat
Axsome outlines late-stage pipeline advancements and targets cash flow positivity amid 72% revenue growth - MSN
Axsome Therapeutics (NASDAQ:AXSM) Announces Quarterly Earnings Results, Beats Estimates By $0.08 EPS - MarketBeat
Federated Hermes Inc. Acquires Shares of 25,990 Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
Axsome Therapeutics Jumps 5% as Q2 Revenue Surpasses Projections - MSN
1.55%
0.38%
자본화:
|
볼륨(24시간):